Conjugated Linoleic Acid for Sports & Fitness
What is it?
Conjugated linoleic acid (CLA) is a slightly altered form of the essential fatty acid
linoleic acid.
Where is it found?
CLA is found mainly in dairy products and
also in beef and poultry,
eggs, and corn oil. Bacteria that live in
the intestine of humans can produce CLA from linoleic acid, but supplementation of a rich
source of linoleic acid did not produce increases in blood levels of CLA in one human
study.1 CLA is available as a supplement.
Why do athletes use it?*
Some athletes say that CLA
- helps reduce body fat.
- helps increase muscle strength and size.
What do the advocates say?*
Research suggests that conjugated linoleic acid (CLA) may help reduce body fat and increase
muscle strength and size. There are at least seven human studies (two double-blind and some
controlled) showing significant reduction of abdominal obesity and body fat mass in overweight
and moderately obese people. However, since most of the studies involved a small number of
participants and were short in duration, larger double-blind studies are needed to further
document the benefits and mechanisms of action.
Although CLA promotes weight loss, which is good for heart health, it is important to
monitor HDL (“good”) cholesterol levels as CLA may reduce them.
How much is usually taken by athletes?
CLA is a slightly altered form of the essential fatty acid linoleic acid. Animal research
suggests an effect of CLA supplementation on reducing body fat.2 3
Controlled human research has reported that 5.6 to 7.2 grams per day of CLA produces only
non-significant gains in muscle size and strength in experienced and inexperienced
weight-training men.4 5 6 A double-blind study of a group of
trained men and women reported reduced body fat in the upper arm after 12 weeks of
supplementation with 1.8 grams per day of CLA.7 Further research using more
accurate techniques for measuring body composition is needed to confirm these findings.
Are there any side effects or interactions?
Overweight volunteers who took 4.5 grams of
CLA per day for one year had an increase in their blood levels of lipoprotein(a), a risk
factor for heart disease.8 In a double-blind study of human volunteers,
supplementation with 4.2 grams per day of a mixture of cis-9,trans-11 CLA and trans-10,cis-12
CLA for three months increased the concentration of C-reactive protein, another risk factor
for heart disease.9 In a study of healthy volunteers, supplementing with 4.5 grams
of CLA per day for 12 weeks caused an impairment of blood vessel function (endothelial
dysfunction), which is believed to be associated with an increased risk of heart
disease.10 Taken together, these findings suggest that long-term use of CLA could
increase the risk of developing heart
disease.
In a double-blind study of people with type 2
diabetes, supplementing with 3 grams of CLA per day for eight weeks significantly
increased blood glucose levels by 6.3% and decreased insulin sensitivity.11 A
reduction in insulin sensitivity was also seen in a study of overweight men without diabetes
after treatment with 3 grams of CLA per day for three months,12 although in a study
of young sedentary men, 4 grams of CLA per day for eight weeks improved insulin
sensitivity.13 Thus, although the studies are conflicting, CLA may be harmful for
some people who have, or are at risk of developing, diabetes. One unpublished human trial
reported isolated cases of gastrointestinal upset.14
At the time of writing, there were no well-known drug interactions
with conjugated linoleic acid.
*Athletes and fitness advocates may claim benefits for CLA based on
their personal or professional experience. These are individual opinions and testimonials that
may or may not be supported by controlled clinical studies or published scientific articles on
CLA. For more complete and detailed information, including references and safety information,
see CLA as a nutritional supplement.
References:1. Herbel BK, McGuire MK, McGuire MA, et al. Safflower oil consumption
does not increase plasma conjugated linoleic acid concentrations in humans. Am J Clin
Nutr 1998;67:332–7.
2. West DB, Delany JP, Camet PM, et al. Effects of conjugated linoleic
acid on body fat and energy metabolism in the mouse. Am J Physiol
1998;275:R667–72.
3. Park Y, Albright KJ, Liu W, et al. Effect of conjugated linoleic acid
on body composition in mice. Lipids 1997;32:853–8.
4. Ferreira M, Krieder R, Wilson M. Effects of CLA supplementation during
resistance training on body composition and strength. J Strength Conditioning Res
1998;11:280.
5. Kreider RB, Ferreira MP, Greenwood M, et al. Effects of conjugated
linoleic acid supplementation during resistance training on body composition, bone density,
strength, and selected hematological markers. J Strength Cond Res 2002;16:325-34.
6. Lowery LM, Appicelli PA, Lemon PWR. Conjugated linoleic acid enhances
muscle size and strength gains in novice bodybuilders. Med Sci Sport Excer
1998;30:S182 [abstract]
7. Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces
body fat in healthy exercising humans. J Int Med Res 2001;29:392–6.
8. Gaullier JM, Halse J, Hoye K, et al. Conjugated linoleic acid
supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin
Nutr 2004;79:1118–25.
9. Smedman A, Basu S, Jovinge S, Fredrikson GN, Vessby B. Conjugated
linoleic acid increased C-reactive protein in human subjects. Br J Nutr
2005;94:791–5.
10. Taylor JS, Williams SR, Rhys R, et al. Conjugated linoleic acid
impairs endothelial function. Arterioscler Thromb Vasc Biol 2006;26:307–12.
11. Moloney F, Yeow TP, Mullen A, et al. Conjugated linoleic acid
supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2
diabetes mellitus. Am J Clin Nutr 2004;80:887-95.
12. Riserus U, Vessby B, Arnlov J, Basu S. Effects of cis-9,trans-11
conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and
proinflammatory markers in obese men. Am J Clin Nutr 2004;80:279–83.
13. Eyjolfson V, Spriet LL, Dyck DJ. Conjugated linoleic acid improves
insulin sensitivity in young, sedentary humans. Med Sci Sports Exerc
2004;36:814–20.
14. Thom E. A pilot study with the aim of studying the efficacy and
tolerability of Tonalin CLA on the body composition in humans. Lillestrom, Norway: Medstat
Research Ltd., July 1997 [unpublished].